Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2371 to 2380 of 2607 total matches.

OncoScint for Detetion of Disseminated Colorectal and Ovarian Cancer

   
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993  (Issue 898)
. The Medical Letter, Inc. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com ...
Indium 111 In-satumomab pendetide (CYT-103, OncoScint CR/OV Kit - Cytogen), a new intravenous imaging agent, has been approved by the US Food and Drug Administration for detection of extrahepatic spread of colorectal and ovarian tumors.
Med Lett Drugs Ther. 1993 Jun 11;35(898):52-3 |  Show IntroductionHide Introduction

Radioactive Strontium-89 for Painful Bone Metastases

   
The Medical Letter on Drugs and Therapeutics • Oct 29, 1993  (Issue 908)
or omission. Copyright  1988-2002. The Medical Letter, Inc. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB ...
Strontium-89 chloride was recently approved for marketing by the US Food and Drug Administration. It is offered for relief of pain caused by metastatic bone lesions
Med Lett Drugs Ther. 1993 Oct 29;35(908):102 |  Show IntroductionHide Introduction

Home Testing of Cholesterol

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 1994  (Issue 932)
. Copyright  1988-2002. The Medical Letter, Inc. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http ...
The new Advanced Care Cholesterol Test (Johnson & Johnson) now being advertised to the general public encourages patients to test their own serum cholesterol concentrations. Approved by the US Food and Drug Administration, this product is available in pharmacies without a prescription at a cost of about $20 for a single determination.
Med Lett Drugs Ther. 1994 Sep 30;36(932):85-6 |  Show IntroductionHide Introduction

Bicalutamide for Prostate Cancer

   
The Medical Letter on Drugs and Therapeutics • Jun 21, 1996  (Issue 977)
resulting from any error, inaccuracy or omission. Copyright  1988-2002. The Medical Letter, Inc. Phone: 1 ...
Bicalutamide (Casodex - Zeneca), an oral nonsteroidal antiandrogen similar to flutamide (Eulexin - Medical Letter, 31:72, 1989), is now available in the USA for treat-ment of advanced prostate cancer. The drug is recommended by the manufacturer for use concurrently with an analog of luteinizing hormone-releasing hormone (LHRH) such as leuprolide (Lupron; Lupron Depot) or goserelin (Zoladex -Medical Letter, 32:102, 1990).
Med Lett Drugs Ther. 1996 Jun 21;38(977):56-7 |  Show IntroductionHide Introduction

Simethicone for Gastrointestinal gas

   
The Medical Letter on Drugs and Therapeutics • Jun 21, 1996  (Issue 977)
or omission. Copyright  1988-2002. The Medical Letter, Inc. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB ...
Gastrointestinal gas may cause symptoms when excessive amounts become trapped in the stomach and intestinal tract. Simethicone (Gas-X, Maalox Anti-Gas, Mylanta Gas Relief, Mylicon, Phazyme), sold over-the-counter in capsules, tablets and infant drop formulations, is being heavily advertised to the public for symptomatic treatment of flatulence and gastric bloating. According to a recent press release, 'Phazyme works fast so people can continue living active lives and eating the foods they love without fear of embarrassment.' Products that combine one or more antacids with simethicone...
Med Lett Drugs Ther. 1996 Jun 21;38(977):57-8 |  Show IntroductionHide Introduction

Zinc for the Common Cold

   
The Medical Letter on Drugs and Therapeutics • Jan 31, 1997  (Issue 993)
resulting from any error, inaccuracy or omission. Copyright  1988-2002. The Medical Letter, Inc. Phone: 1 ...
Results of a recent study suggested that zinc gluconate may be effective in treating the common cold (SB Mossad et al, Ann Intern Med, 125:81, July 15, 1996). Zinc gluconate lozenges, sometimes combined with vitamin C or other ingredients, are available in pharmacies and health food stores throughout the USA.
Med Lett Drugs Ther. 1997 Jan 31;39(993):9-10 |  Show IntroductionHide Introduction

Glucosamine for Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Sep 26, 1997  (Issue 1010)
. The Medical Letter, Inc. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com ...
The Medical Letter has received many inquiries about use of glucosamine, a basic constituent of articular cartilage glycosaminoglycans, for treatment of arthritis. A recently published book (The Arthritis Cure), several television news shows, and articles in The New York Times have suggested it may be effective for treatment of osteoarthritis. Glucosamine is sold as a 'dietary supplement' in the USA.
Med Lett Drugs Ther. 1997 Sep 26;39(1010):91-2 |  Show IntroductionHide Introduction

Raloxifene for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998  (Issue 1022)
. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com The Medical Letter, Vol ...
Raloxifene (Evista - Lilly), a benzothiophene that acts on estrogen receptors, has recently been marketed for prevention of postmenopausal osteoporosis. Only estrogen (alone or in combination with a progestin) and the bisphosphonate alendronate (Fosamax) were previously approved by the FDA for this indication.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):29-30 |  Show IntroductionHide Introduction

Prosorba Column for Rheumatoid Arthritis

   
The Medical Letter on Drugs and Therapeutics • Jul 30, 1999  (Issue 1058)
. Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com The Medical Letter, Vol ...
Prosorba, an antibody-adsorbing column used with plasmapheresis, has been approved by the FDA for treatment of moderate-to-severe rheumatoid arthritis in patients refractory or intolerant to methotrexate and other disease-modifying anti-rheumatic drugs (DMARDs).
Med Lett Drugs Ther. 1999 Jul 30;41(1058):67-70 |  Show IntroductionHide Introduction

In Brief: Plan B OTC

   
The Medical Letter on Drugs and Therapeutics • Sep 11, 2006  (Issue 1243)
the pregnancy rate to 1%, compared to an expected rate of 8% (Task Force on Postovulatory Methods of Fertility ...
The FDA has approved over-the-counter (OTC) sales of Plan B (Duramed), an emergency contraceptive package that contains two 0.75-mg tablets of levonorgestrel, to women ≥18 years old. Younger women still require a prescription. In one trial, two levonorgestrel 0.75-mg tablets taken 12 hours apart, the first within 72 hours after unprotected intercourse, decreased the pregnancy rate to 1%, compared to an expected rate of 8% (Task Force on Postovulatory Methods of Fertility Regulation, Lancet 1998; 352:428). How high doses of a progestin taken after coitus prevent pregnancy is unclear; they may...
Med Lett Drugs Ther. 2006 Sep 11;48(1243):75 |  Show IntroductionHide Introduction